Plan B Switch NDA Could Be Supported By New Study Findings
This article was originally published in The Tan Sheet
Executive Summary
Study results indicating a single 1.5 mg dose of levonorgestrel is as effective as two .75 mg doses 12 hours apart could help Women's Capital Corp. in its attempt to switch its emergency contraceptive Plan B over-the-counter
You may also be interested in...
OTC Emergency Contraceptive Application Nearing FDA Panel Review
Women's Capital Corporation's application to switch its Plan B emergency contraceptive from Rx to OTC status is expected to be considered by an FDA advisory panel in mid December
WCC Plan B OTC Marketing Partnership Sought Pending Switch Approval
Women's Capital Corporation "is in discussions with a number of potential strategic marketers" to sell an OTC version of its Plan B emergency contraceptive pending approval of the firm's April 21 switch application
Plan B Label Comprehension, Actual Use Studies Completed
More than 93% of women understood the Plan B emergency contraceptive is to prevent pregnancy after unprotected sex, does not prevent transmission of HIV/AIDS and should not be used by women who are already pregnant, according to a label comprehension study published in the August Obstetrics & Gynecology